secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2022-03-14T23:59:59+00:00
Accession:  0001193125-22-074127
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences receives Nasdaq delisting notice for equity shortfall
---------------------------------------------------------------------------

- Notice received March 8, 2022: stockholders' equity in 2021 10-K fails Nasdaq Rule 5450(b)(1).
- Company has 45 days to submit a plan to regain compliance with the Rule.
- If plan accepted, Nasdaq may grant up to 180 days from notice date for evidence of compliance.
- If plan rejected or extension denied, Company may appeal to Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/0001193125-22-074127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/d316228d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-074127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer